In relation to the ACCC proceeding against MG in the Federal Court of Australia, Murray Goulburn Co-operative Co. Limited (MG) has agreed a settlement in principle with the Australian Competition and Consumer Commission (ACCC) where the settlement is subject to federal court approval.
MG and former Managing Director Mr. Gary Helou contravened the Australian Consumer Law in the period 29 February 2016 to 27 April 2016. The ACCC will apply to the Federal Court seeking declarations in relation to representations made regarding the FY16 farmgate milk price. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]
Against MG and Mr. Helou, the ACCC will seek a pecuniary penalty against Mr. Helou and costs orders. MG and Mr. Helou will agree to the contraventions and the costs orders against each of them under the settlement and Mr. Helou will agree to the proposed penalty. MG confirms that the ACCC will not seek a penalty against the company.
Murray Goulburn is pleased to have reached an agreement with the ACCC on this matter, MG Chairman, John Spark said. For court approval of the settlement the matter is due to come before the Federal Court.
The ACCC reached an agreement with MG’s former Chief Financial Officer Mr. Bradley Hingle, to dismiss its proceeding against Mr. Hingle.
For the year ended 30 June 2018, the Unit Trust reported nil profit after income tax similar to the 2017 $nil. The distribution to unitholders on 15 May 2018, represented a return of capital from Murray Goulburn of 0.80 cents per unit following completion of the agreement for the sale of the Saputo transaction. The value of Unit Trust assets at 30 June 2018 of $52,057,745 compared to the 2017 asset of $132,315,558 were valued at fair value through profit or loss. That financial report is available on the parent entity’s web site and has been released to the Australian Securities Exchange (ASX) in conjunction with this report
MGC traded at a market price of $0.310 with a daily price change of -3.125% which is near to its 52-week high. The stock over the 12 months period has seen a performance change of 159.14% and 3.23% over the past 1 month. The market capitalization of the stock is $69.41 million with 216.91 million as number of shares outstanding.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
Join Our Discussion
Start discussion with value Investors for ASX Stock Market Investment and Opinion.
6 Cannabis Stocks under Investor’s Limelight…
Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.
Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.
Click here for your FREE Report
